Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.24.3
STOCKHOLDERS' EQUITY (Details)
 1 Months Ended 3 Months Ended 6 Months Ended
Sep. 08, 2023
USD ($)
D
$ / shares
shares
Oct. 25, 2022
USD ($)
$ / shares
shares
Jan. 31, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
$ / shares
shares
Mar. 31, 2024
USD ($)
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
shares
Dec. 31, 2023
$ / shares
shares
Oct. 31, 2022
$ / shares
shares
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares       12,132,416   12,132,416      
Proceeds from exercise of warrants, net of issuance costs | $           $ 43,849,468 $ 3    
Exercise of warrants into common shares | $         $ 2,298,143        
Common stock, shares authorized       170,000,000   170,000,000   170,000,000  
Common stock par value | $ / shares       $ 0.00001   $ 0.00001   $ 0.00001  
September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Gross proceeds | $ $ 24,500,000                
Net proceeds | $ $ 22,200,000                
Common Stock                  
STOCKHOLDERS' EQUITY                  
Exercise of warrants into common shares (in shares)         547,177        
Exercise of warrants into common shares | $         $ 5        
Conversion of pre-funded warrants into common shares (in shares)         9,890,099        
Common Stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Conversion of pre-funded warrants into common shares (in shares)           903,956      
Preferred Stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Number of shares converted 905.24                
Common Stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Convertible preferred shares issued 9,947,684                
Series E Warrants | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Share price | $ / shares $ 20,000                
Series E-1 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Shares issued 1,225                
Conversion price per share | $ / shares $ 1.82                
Gross proceeds from stockholders' equity | $ $ 17,820,000                
Convertible preferred shares issued 13,461,538                
Series E-2 Preferred Stock                  
STOCKHOLDERS' EQUITY                  
Preferred stock, share issued       237.50   237.50   319.76  
Preferred stock, share outstanding       237.50   237.50   319.76  
Series E-2 Preferred Stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Conversion of pre-funded warrants into common shares (in shares)           82.26      
Common stock par value | $ / shares $ 1.82                
Preferred stock, share outstanding       237.50   237.50   319.76  
Series E-2 Preferred Stock | Common Stock                  
STOCKHOLDERS' EQUITY                  
Conversion of pre-funded warrants into common shares (in shares)         903,956        
Series E-3 preferred stock                  
STOCKHOLDERS' EQUITY                  
Preferred stock, share issued       202.50   202.50   0  
Preferred stock, share outstanding       202.50   202.50   0  
Series E-3 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Conversion price per share | $ / shares $ 3.185   $ 3.185            
Convertible preferred shares issued 13,846,154                
Conversion of pre-funded warrants into common shares (in shares)           12,574,557      
Number of shares converted           2,002.50      
Preferred stock, share outstanding       202.50   202.50      
Series E-3 preferred stock | Common Stock                  
STOCKHOLDERS' EQUITY                  
Conversion of pre-funded warrants into common shares (in shares)       2,684,458          
Series E-4 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Conversion price per share | $ / shares $ 4.7775                
Convertible preferred shares issued 7,179,487                
Tranche A and B Warrants | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Gross proceeds from stockholders' equity | $ $ 4,800,000                
October 2022 Public Offering and Private Placement                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares   3,275,153              
Gross proceeds | $   $ 10,700,000              
Proceeds from exercise of warrants, net of issuance costs | $           $ 1,100,000      
Exercise price of warrants (in dollars per share) | $ / shares   $ 2.085              
Class of warrant or rights from which warrants or rights exercisable. | $ / shares   $ 0.00001              
Estimated offering expenses | $   $ 9,600,000              
Number of warrants exercised           547,177      
October 2022 Public Offering and Private Placement | Common Stock                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares   1,875,945              
Exercise price of warrants (in dollars per share) | $ / shares   $ 1.96              
Common Stock | October 2022 Public Offering and Private Placement                  
STOCKHOLDERS' EQUITY                  
Conversion of pre-funded warrants into common shares (in shares)           1,079,132 0    
Prefunded Warrant | October 2022 Public Offering and Private Placement                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares   1,875,945              
Exercise price of warrants (in dollars per share) | $ / shares   $ 2.08499              
pre-funded warrants           1,079,132      
Tranche A Warrants                  
STOCKHOLDERS' EQUITY                  
Exercise of warrants into common shares | $         $ 47,577,000        
Tranche A Warrants | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Warrants term     10 days            
Tranche A Warrants | Series E-3 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Exercise of warrants into common shares (in shares)     2,205.00            
Proceeds from exercise of warrants, net of issuance costs | $     $ 44,100,000            
Exercise of warrants into common shares | $     $ 42,800,000            
2023 Tranche A Preferred Warrants | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Proceeds from exercise of warrants, net of issuance costs | $ $ 44,100,000                
2023 Tranche A Preferred Warrants | Series E-3 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares 2,205                
Number of days | D 10                
2023 Tranche B Preferred Warrants | Series E-4 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares 1,715                
Proceeds from exercise of warrants, net of issuance costs | $ $ 34,300,000                
Number of days | D 10                
2022 Pre-Funded Common Warrants                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares                 1,875,941
2022 Common Warrants                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares                 5,151,098
Warrants term                 5 years
Exercise price of warrants (in dollars per share) | $ / shares                 $ 1.96